Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Coeptis Therapeutics Holdings (COEPW) Long-Term Debt Issuances (2023 - 2025)

Historic Long-Term Debt Issuances for Coeptis Therapeutics Holdings (COEPW) over the last 3 years, with Q1 2025 value amounting to $990000.0.

  • Coeptis Therapeutics Holdings' Long-Term Debt Issuances fell 2666.67% to $990000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $990000.0, marking a year-over-year decrease of 5050.0%. This contributed to the annual value of $1.8 million for FY2024, which is 18461.54% up from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Long-Term Debt Issuances of $990000.0 as of Q1 2025, which was down 2666.67% from $500000.0 recorded in Q2 2024.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Long-Term Debt Issuances peaked at $1.3 million during Q1 2024, and registered a low of $150000.0 during Q3 2023.
  • In the last 3 years, Coeptis Therapeutics Holdings' Long-Term Debt Issuances had a median value of $425000.0 in 2023 and averaged $581666.7.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first soared by 4285.71% in 2024, then tumbled by 2666.67% in 2025.
  • Quarter analysis of 3 years shows Coeptis Therapeutics Holdings' Long-Term Debt Issuances stood at $150000.0 in 2023, then skyrocketed by 233.33% to $500000.0 in 2024, then skyrocketed by 98.0% to $990000.0 in 2025.
  • Its last three reported values are $990000.0 in Q1 2025, $500000.0 for Q2 2024, and $1.3 million during Q1 2024.